RECRUITING

Quantitative MRI for Myelofibrosis

Talk to us

Conditions

Myelofibrosis

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study is for the development and validation of functional magnetic resonance imaging (MRI) parameters as biomarkers for analyzing extent of disease and quantifying response to treatment in patients with myelofibrosis.

Official Title

Quantitative MRI for Myelofibrosis - MRI Parameters as Biomarkers for Analyzing Extent of Disease and Measuring Response to Treatment

Quick Facts

Study Start:2014-12-22
Study Completion:2026-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT01973881

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 99 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Male /female subjects over the age of 18
  2. 2. Diagnosis of primary myelofibrosis, post-polycythemia vera myelofibrosis, or post-essential thrombocythemia myelofibrosis.
  3. 3. No contraindications to MRI
  4. 4. Able to undergo MRI without anesthesia
  1. 1. Patients with pacemakers or other implanted magnetic devices that may malfunction or move because of the strong magnetic field inside the MRI room and scanner.
  2. 2. Any prior adverse event associated with MRI that is not related to injection of contrast agents or other medicines.

Contacts and Locations

Study Contact

Gary Luker, M.D.
CONTACT
734-763-5476
gluker@umich.edu

Principal Investigator

Gary Luker, M.D.
PRINCIPAL_INVESTIGATOR
University of Michigan Hospital

Study Locations (Sites)

University of Michigan Hospital
Ann Arbor, Michigan, 48109
United States

Collaborators and Investigators

Sponsor: University of Michigan

  • Gary Luker, M.D., PRINCIPAL_INVESTIGATOR, University of Michigan Hospital

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2014-12-22
Study Completion Date2026-12

Study Record Updates

Study Start Date2014-12-22
Study Completion Date2026-12

Terms related to this study

Additional Relevant MeSH Terms

  • Myelofibrosis